Skip to main content
Clinical Trials/ACTRN12616000014459
ACTRN12616000014459
Terminated
未知

Investigating the neurobiological and neurocognitive effects of repeated sessions of tDCS and itDCS in schizophrenia.

Dr Kate Hoy0 sites60 target enrollmentJanuary 12, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Kate Hoy
Enrollment
60
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 12, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Kate Hoy

Eligibility Criteria

Inclusion Criteria

  • competent to consent based on their ability to provide a spontaneous narrative description of the key elements of the study, as assessed by a clinical staff member independent of the research project
  • \-have a diagnosis of schizophrenia or schizoaffective disorder as confirmed by the MINI
  • \-are between the ages of 18 and 60
  • \- have been on a stable dose of medication for at least 4 weeks

Exclusion Criteria

  • \-have a DSM\-IV history of substance abuse or dependence in the last 6 months
  • \-have a concomitant major and unstable medical or neurological illness
  • \-are pregnant
  • \-are currently taking any medication shown to interfere with the effects of tDCS; namely benzodiazepines or tegretol.

Outcomes

Primary Outcomes

Not specified

Similar Trials